- Trials with a EudraCT protocol (72)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006). | |
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records. |
Study title: Randomised study to investigate the effects on growth, on uraemic toxins profile and on the safety of recombinant human growth hormone treatment in very young children with growth retardation secondary to chronic renal insufficiency (CRI). |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41791 |
Study title: Randomised Study to Investigate the Effects on Growth, on Uremic Toxins Profile and on Renal Function of Recombinant Human Growth Hormone Treatment in Very Young Children With Growth Retardation Secondary To Chronic Renal Insufficiency. |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41790 |
Study title: TREATMENT OF 94 PATIENTS WITH TURNER SYNDROME WITH RECOMBINANT HUMAN GROWTH HORMONE FOR TWO YEARS. THE RESULT OF A MUNTICENTRIC STUDY IN JAPAN. |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41741 |
Study title: Growth-promoting effect of a recombinant Human Growth Hormone NN-798 on Achondroplasia – A 1-year, comparative study between two dose groups. |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41803 |
Study title: Multicentre clinical trial on the safety and efficacy of recombinant human growth hormone, Norditropin®, in growth retarded children with chronic renal failure. |
Active substance: Somatropin |
Study summary document link (including results): |
View full study record |
Document reference: 41786 |
Study title: A clinical evaluation of the effectiveness and safety of the administration of recombinant human growth hormone in growth hormone deficient children: a multicentre trial conducted in Japan. |
Active substance: Somatropin |
Study summary document link (including results): TRN 86-042 EMA Pediatrics Web Synopsis.pdf |
View full study record |
Document reference: 41662 |